Direct answer
Are energy drinks safe?
Energy drinks legally placed on the European Union market are regulated foods and must comply with applicable food-safety, hygiene, ingredient and labelling requirements. This does not mean that every product is risk-free for every person or in every quantity. Safety depends on the exact product, dose, consumer and pattern of use.
EU General Food Law states: “Food shall not be placed on the market if it is unsafe.” Food businesses are responsible for compliance, while national authorities monitor and enforce the rules. A product suspected of being unsafe may be restricted, withdrawn or recalled. [1]
The correct distinction is therefore between a compliant product consumed under its intended conditions and excessive, unsuitable or otherwise higher-risk consumption—not between “safe ingredients” and unfamiliar-sounding names.
Food-safety controls
Energy drink formulations vary, but may include water, sugar or sweeteners, caffeine, acids, flavourings, vitamins and other permitted ingredients. Products sold legally in the EU are subject to rules covering composition, hygiene, manufacturing controls, traceability, consumer information and corrective action.
The European Commission states that only additives whose proposed uses were considered safe are included on the EU list. Food businesses must also operate hygiene procedures based on HACCP principles and verify compliance within the activities they control. [3] [2] [1]
Legal compliance provides a regulated safety framework. It does not make unlimited consumption safe, eliminate individual sensitivity or prevent the possibility of a defective batch and subsequent recall.
Children, adolescents and sales restrictions
EU law does not require the same warning for children on every drink marketed as an energy drink. Specified beverages containing more than 150 mg of caffeine per litre must display the warning:
“High caffeine content. Not recommended for children or pregnant or breast-feeding women.”
Whether this requirement applies depends on the drink’s caffeine concentration and legal category. The rule also contains defined exceptions for certain coffee- and tea-based beverages. [4]
Several EU Member States have introduced restrictions on energy drink sales to minors. Definitions, age limits and enforcement rules vary by jurisdiction and should be checked against current national law. [7]
Excessive caffeine exposure in young people may contribute to sleep disruption, anxiety, increased heart rate, palpitations and other unwanted effects. Caffeine from coffee, tea, cola, chocolate, energy drinks, supplements and medicines should be considered together. Health Canada sets a precautionary recommended maximum of 2.5 mg per kilogram of body weight per day for children and adolescents up to 18 years of age. [8] [9]
In its 2026 update, the BfR found the evidence on acute or chronic moderate energy drink consumption in children and adolescents to be limited. Considering caffeine alone, it reported no current evidence that health effects are to be expected at the EFSA reference level of 3 mg per kilogram of body weight, while identifying children and adolescents as a risk group when acute high consumption exceeds that level. The BfR rated the quality of the available data as moderate and noted that important data remain missing or contradictory. [6]
Caffeine levels for healthy adults
EFSA concluded that, for healthy non-pregnant adults, a single caffeine dose of up to 200 mg—about 3 mg/kg for a 70 kg adult—does not raise safety concerns. Habitual consumption of up to 400 mg per day, from all dietary sources combined, also does not raise safety concerns. [5]
EFSA reference for a single dose in healthy adults.
EFSA reference for habitual total intake in healthy non-pregnant adults.
The BfR’s 2026 assessment likewise concluded that acute, moderate energy drink consumption supplying no more than 200 mg of caffeine as a single dose is not expected to cause health effects in healthy adults. Its conclusion concerned occasional moderate intake under normal conditions; it did not extend to high consumption, susceptible individuals or every possible formulation. [6]
These figures are safety reference values, not intake targets and not a guarantee that every individual will experience no effects. Body mass, habitual intake, genetics, sensitivity, sleep status, pregnancy, medical conditions, medicines, dose and timing may all influence response.
EFSA also notes that 100 mg consumed close to bedtime may affect sleep in some adults. For pregnant women, habitual caffeine intake up to 200 mg per day from all sources does not raise safety concerns for the fetus according to the EFSA assessment. [5]
Caffeine is the same compound, whatever its source
Caffeine is the same chemical compound whether it occurs naturally in coffee, tea, guarana or yerba mate, or is produced and added as an ingredient. When chemical identity, purity and dose are equivalent, caffeine acts through the same physiological mechanisms.
The FDA states that there is no difference in how the body handles naturally occurring and added caffeine. A clinical study comparing equal caffeine doses in coffee and a sugar-free energy drink found very similar overall caffeine exposure; the study was funded by the American Beverage Association, and its lead author declared beverage-industry consulting. Research comparing botanical caffeine sources with synthetic caffeine has likewise reported broadly similar pharmacokinetic and nervous-system effects. [8] [10] [11]
This does not make all caffeinated products identical. Serving size, concentration, consumption speed, sugar content and other compounds can differ. The practical rule is to count the total caffeine dose from every source.
B vitamins in energy drinks
Many energy drinks contain added B vitamins, commonly riboflavin (B2), niacin (B3), pantothenic acid (B5), vitamin B6 and vitamin B12. The selection and amount vary by product and should be checked on the nutrition label.
B vitamins do not provide calories and are not themselves an energy source. Several B vitamins do, however, contribute to the body’s normal energy-yielding metabolism—the processes through which energy from carbohydrate, fat and protein is made available for use.
These are authorised EU physiological-function claims and may be used only when a food contains the legally required amount of the relevant vitamin. They do not mean that progressively larger vitamin doses create unlimited energy, alertness or performance. [16]
Natural and added vitamins
A vitamin’s function is not determined simply by describing its source as natural or synthetic. When the chemical form is the same, the body can use a naturally occurring and an added vitamin for the same physiological functions. However, vitamins may exist in different chemical forms, and stability, absorption and bioavailability can differ. Vitamin B12 bioavailability varies by source, while folic acid used in fortified foods is generally absorbed more readily than naturally occurring food folate. [18] [19]
The scientifically accurate conclusion is that origin alone does not determine a vitamin’s physiological function. Chemical form, dose, bioavailability and the consumer’s nutritional status matter. EU rules specify which vitamins and chemical forms may be added to foods. [17]
Taurine, L-carnitine, guarana and ginseng
The presence of an unfamiliar ingredient name is not evidence that a product is harmful. Ingredient safety must be assessed according to the exact substance and form, purity, concentration, total amount consumed, possible interactions and the characteristics of the consumer.
Taurine
Taurine is a naturally occurring compound found in the human body and in foods, particularly meat, fish and seafood. It is not a stimulant and should not be confused with caffeine. In 2009, EFSA evaluated taurine and D-glucurono-γ-lactone at the levels covered by its energy drink assessment and concluded that the estimated exposure was not of safety concern. EFSA also considered an additive interaction between taurine and caffeine on diuretic effects unlikely. [20] [21]
EFSA’s conclusion applied to the substances, concentrations and consumption assumptions examined. It was not an unrestricted guarantee for every possible formulation or dose.
L-carnitine
L-carnitine is produced naturally by the human liver, kidneys and brain. It is also present in ordinary foods, especially red meat, and in smaller amounts in poultry, fish and dairy products. Healthy adults normally synthesise sufficient carnitine. [23]
EFSA has evaluated L-carnitine-L-tartrate as a source of L-carnitine for specified nutritional uses. This is evidence that a particular form underwent formal scientific assessment; it should not be represented as an unlimited safety or performance conclusion for every carnitine-containing product. [22]
Guarana
Guarana seeds naturally contain caffeine. Caffeine from guarana contributes to the product’s total caffeine content and is the same caffeine molecule found in other sources. Guarana should therefore be included when calculating total caffeine intake. An assessment of caffeine does not automatically constitute a complete assessment of every other compound in every guarana extract. [25] [26]
Ginseng
Ginseng is a plant ingredient used in some traditional preparations, teas, foods, supplements and energy drinks. It is not caffeine, and its presence alone does not establish harm. Extracts may differ in composition and concentration. The U.S. National Center for Complementary and Integrative Health states that short-term oral use of Asian ginseng in recommended amounts appears safe for most people, while questions remain about long-term use and interactions with some medicines. [24]
Taurine, L-carnitine, guarana or ginseng on an ingredient list does not by itself prove that an energy drink is harmful—or beneficial. The exact ingredient, form, dose, total exposure and consumer characteristics must be evaluated.
Reported adverse events and causation
News reports, spontaneous adverse-event reports and medical case reports have described symptoms or serious medical events occurring after energy drink consumption. Such reports should be investigated and not dismissed. However, an event occurring after consumption does not by itself demonstrate that the drink was the sole cause.
A review of published cardiovascular case reports identified circumstances including heavy consumption, alcohol or drug co-ingestion and previously unidentified cardiac conditions. The authors explicitly stated that causality could not be inferred from the case series. [12]
Medical causation requires assessment of the amount consumed, total caffeine dose, other substances, medicines, pre-existing or undiagnosed conditions, exercise, hydration, timing, biological plausibility, competing explanations and the wider clinical and epidemiological evidence.
It is therefore inaccurate to present every reported incident as proof that an energy drink alone caused illness or death. It would be equally inaccurate to claim that an energy drink can never contribute to an adverse event. The strength of evidence and the circumstances must be evaluated case by case.
Controlled findings also matter
A meta-analysis of 17 randomised trials found that energy drinks produced a short-term rise in systolic blood pressure, with a pooled estimate of 4.71 mmHg at 60–80 minutes. This is a measured physiological effect, not proof that all consumers develop cardiovascular disease. [13]
In a small crossover trial, a high-volume serving (946 ml, 320 mg caffeine) produced larger changes in corrected QT interval at two hours and systolic blood pressure at six hours than a caffeine-only control. This does not establish the same result for a standard-sized drink. [14]
In 24 patients with familial long QT syndrome, the primary group-level QTc comparison between the energy drink and control was not statistically significant (12 ± 28 ms versus 16 ± 27 ms; p = 0.71). Systolic and diastolic blood pressure increased significantly relative to control, and three individuals experienced a QTc increase of at least 50 ms after the drink. The authors urged caution in this susceptible group. Neither the null group-level result nor the individual observations should be omitted; the study cannot be generalised to healthy adults. [15]
Evidence compared
| Primary source | Population | Exposure | Comparison / design | Observed result | What it cannot prove |
|---|---|---|---|---|---|
| EFSA caffeine opinion, 2015 ↗ | Healthy non-pregnant adults | Up to 200 mg single; 400 mg/day habitual, all sources | Regulatory scientific risk assessment | No safety concern at stated exposure levels | Not a target dose, universal guarantee or child limit. |
| Goldfarb et al., 2014 · PMID 24176062 ↗ | 17 published cardiovascular case reports | Varied; some heavy use or co-ingestions | Case-series review; no matched comparator | Temporally associated serious cases described | Authors explicitly say causality cannot be inferred from series. |
| Gualberto et al., 2024 · PMID 37695306 ↗ | 17 randomised trials in healthy adults | Varied tested energy drinks | Systematic review and meta-analysis of RCTs | Acute systolic BP increase ~4.71 mmHg at 60–80 min | Trial bias concerns; not an estimate of long-term disease risk. |
| Fletcher et al., 2017 · PMID 28446495 ↗ | 18 healthy young volunteers | 946 ml drink with 320 mg caffeine | 320 mg caffeine-only drink; crossover | Higher QTc at 2 h and systolic BP at 6 h in drink arm | High volume; small study; not a claim about a 250 ml can. |
| Gray et al., 2017 · PMID 28189188 ↗ | 24 patients with familial long-QT syndrome | Caffeinated energy drink | Control beverage; randomised crossover | No significant group QTc difference (p=.71); BP increased; three individuals had ≥50 ms QTc prolongation | Susceptible cardiac population; do not generalise to healthy adults. |
Responsible use
- Check caffeine per 100 ml, per serving and per entire container.
- Count caffeine from coffee, tea, cola, chocolate, guarana, supplements, medicines and energy drinks together.
- Do not treat 200 mg or 400 mg as consumption targets.
- Avoid excessive or very rapid consumption.
- Avoid caffeine late in the day if it affects sleep.
- Do not use caffeine as a substitute for adequate sleep, food or hydration.
- Consider the additional risks associated with alcohol, other stimulants and relevant medicines.
- Seek professional advice when pregnant, breastfeeding, taking medication, living with a medical condition or experiencing adverse symptoms.
Energy Drink Facts provides general, evidence-based information. It does not provide personalised medical advice and does not replace consultation with a qualified healthcare professional.
Key conclusions
- Energy drinks legally sold in the EU are regulated foods subject to food-safety and labelling requirements.
- Compliance does not mean unlimited consumption is safe for every person.
- EU law requires specified beverages above 150 mg of caffeine per litre to state that they are not recommended for children or pregnant or breast-feeding women; several EU countries also restrict energy drink sales to minors.
- For healthy non-pregnant adults, EFSA identifies 200 mg as a single-dose level and 400 mg as a habitual daily level that do not raise safety concerns.
- Caffeine from every dietary source contributes to the same total intake.
- B vitamins support normal physiological processes but do not themselves provide calories.
- Unfamiliar ingredient names are not evidence of harm; dose, form, exposure and consumer characteristics matter.
- An adverse event reported after consumption is not automatically proof of sole causation.
Performance studies and safety
Some controlled studies report short-term performance effects for particular formulations and tasks; those findings do not establish long-term safety, effectiveness in children or universal benefits. Read the study designs and limits in Performance research examples →.
Scientific and regulatory sources
- European Union — Regulation (EC) No 178/2002, General Food Law (opens in a new tab)
Articles 14 and 17–19: safety, responsibility, traceability, withdrawal and recall.
- European Union — Regulation (EC) No 852/2004 on food hygiene (opens in a new tab)
Food hygiene requirements and procedures based on HACCP principles.
- European Commission — Food additives (opens in a new tab)
Authorisation, safety assessment and conditions of use for additives in the EU.
- European Union — Regulation (EU) No 1169/2011 (opens in a new tab)
Annex III: mandatory warning for specified high-caffeine beverages.
- EFSA — Scientific Opinion on the safety of caffeine (opens in a new tab)
EFSA Journal. 2015;13(5):4102. DOI: 10.2903/j.efsa.2015.4102
- German Federal Institute for Risk Assessment (BfR) — Updated energy drink assessment (opens in a new tab)
Opinion No 037/2026, 7 July 2026: acute and chronic consumption, with particular attention to children and adolescents.
- European Parliament — Energy drinks consumption in minors (opens in a new tab)
EPRS briefing on EU and national approaches, 2025.
- U.S. FDA — Spilling the Beans: How Much Caffeine Is Too Much? (opens in a new tab)
Caffeine sources, individual sensitivity and advice concerning children and teenagers.
- Health Canada — Caffeine in Foods (opens in a new tab)
Recommended maximum daily intakes and caffeine amounts in common foods and drinks.
- White et al. — Caffeine pharmacokinetics in coffee and energy drink (opens in a new tab)
Clinical Toxicology. 2016;54(4):308–312. PMID: 27100333. DOI: 10.3109/15563650.2016.1146740. Funded by the American Beverage Association; the lead author disclosed beverage-industry consulting.
- Krieger et al. — Natural and synthetic caffeine (opens in a new tab)
Clinical and Translational Science. 2016;9(5):246–251. PMID: 27320048
- Goldfarb et al. — Review of cardiovascular case reports (opens in a new tab)
American Journal of Cardiology. 2014;113(1):168–172. PMID: 24176062
- Gualberto et al. — Meta-analysis of randomised cardiovascular trials (opens in a new tab)
Nutrition Reviews. 2024. PMID: 37695306. 17 trials; acute blood-pressure outcomes.
- Fletcher et al. — Energy drink versus caffeine control (opens in a new tab)
Journal of the American Heart Association. 2017. PMID: 28446495. 946 ml and 320 mg caffeine.
- Gray et al. — People with familial long QT syndrome (opens in a new tab)
International Journal of Cardiology. 2017. PMID: 28189188. Randomised crossover in 24 patients.
- European Union — Regulation (EU) No 432/2012 (opens in a new tab)
EU list of permitted health claims, including claims for B vitamins.
- European Union — Regulation (EC) No 1925/2006 (opens in a new tab)
Permitted vitamins, minerals and chemical forms added to foods.
- NIH Office of Dietary Supplements — Vitamin B12 (opens in a new tab)
Functions, sources, forms and bioavailability of vitamin B12.
- NIH Office of Dietary Supplements — Folate (opens in a new tab)
Natural food folate, folic acid and differences in bioavailability.
- EFSA — Taurine and D-glucurono-γ-lactone in energy drinks (opens in a new tab)
EFSA Journal. 2009;7(2):935. DOI: 10.2903/j.efsa.2009.935
- EFSA — Summary of the taurine and glucuronolactone assessment (opens in a new tab)
EFSA explanation of its 2009 scientific opinion.
- EFSA — L-carnitine-L-tartrate assessment (opens in a new tab)
EFSA Journal. 2003;1(12):19. DOI: 10.2903/j.efsa.2003.19
- NIH Office of Dietary Supplements — Carnitine (opens in a new tab)
Human synthesis, dietary sources, absorption and scientific evidence.
- NIH NCCIH — Asian ginseng: usefulness and safety (opens in a new tab)
Evidence, short-term use, uncertainties and possible medicine interactions.
- NIH NCCIH — Energy drinks (opens in a new tab)
Overview of caffeine, guarana and other commonly used ingredients.
- Heckman et al. — Caffeine in foods (opens in a new tab)
Journal of Food Science. 2010;75(3):R77–R87. PMID: 20492310